These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38019911)

  • 1. Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction.
    Hao T; Ji G; Qian M; Li QX; Huang H; Deng S; Liu P; Deng W; Wei Y; He J; Wang S; Gao W; Li T; Cheng J; Tian J; Pan L; Gao F; Li Z; Zhao Q
    Sci Adv; 2023 Dec; 9(48):eadi9967. PubMed ID: 38019911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide releasing hydrogel enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction.
    Yao X; Liu Y; Gao J; Yang L; Mao D; Stefanitsch C; Li Y; Zhang J; Ou L; Kong D; Zhao Q; Li Z
    Biomaterials; 2015 Aug; 60():130-40. PubMed ID: 25988728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy.
    Huang H; Qian M; Liu Y; Chen S; Li H; Han Z; Han ZC; Chen XM; Zhao Q; Li Z
    Elife; 2023 Sep; 12():. PubMed ID: 37695201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell transplantation enhancement in myocardial infarction rat model under ultrasound combined with nitric oxide microbubbles.
    Tong J; Ding J; Shen X; Chen L; Bian Y; Ma G; Yao Y; Yang F
    PLoS One; 2013; 8(11):e80186. PubMed ID: 24244646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembling peptide modified with QHREDGS as a novel delivery system for mesenchymal stem cell transplantation after myocardial infarction.
    Cai H; Wu FY; Wang QL; Xu P; Mou FF; Shao SJ; Luo ZR; Zhu J; Xuan SS; Lu R; Guo HD
    FASEB J; 2019 Jul; 33(7):8306-8320. PubMed ID: 30970221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin enhance efficacy of mesenchymal stem cells treatment for swine myocardial infarction via activation of nitric oxide synthase.
    Song L; Yang YJ; Dong QT; Qian HY; Gao RL; Qiao SB; Shen R; He ZX; Lu MJ; Zhao SH; Geng YJ; Gersh BJ
    PLoS One; 2013; 8(5):e65702. PubMed ID: 23741509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
    Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
    Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction.
    Chen L; Zhang Y; Tao L; Yang Z; Wang L
    Cardiovasc Drugs Ther; 2017 Feb; 31(1):9-18. PubMed ID: 27913896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury.
    Liang H; Hou H; Yi W; Yang G; Gu C; Lau WB; Gao E; Ma X; Lu Z; Wei X; Pei J; Yi D
    Eur Heart J; 2013 Jun; 34(22):1681-90. PubMed ID: 21606086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netrin-1 ameliorates myocardial infarction-induced myocardial injury: mechanisms of action in rats and diabetic mice.
    Ke T; Wu Y; Li L; Liu Y; Yao X; Zhang J; Kong D; Li C
    Hum Gene Ther; 2014 Sep; 25(9):787-97. PubMed ID: 24827071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction.
    Zhang Z; Zhu L; Feng P; Tan Y; Zhang B; Gao E; Wang X; Fan C; Wang X; Yi W; Sun Y
    Cell Death Dis; 2019 Jul; 10(7):530. PubMed ID: 31296837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GDF11 enhances therapeutic efficacy of mesenchymal stem cells for myocardial infarction via YME1L-mediated OPA1 processing.
    Zhao Y; Zhu J; Zhang N; Liu Q; Wang Y; Hu X; Chen J; Zhu W; Yu H
    Stem Cells Transl Med; 2020 Oct; 9(10):1257-1271. PubMed ID: 32515551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
    Huang B; Qian J; Ma J; Huang Z; Shen Y; Chen X; Sun A; Ge J; Chen H
    Stem Cell Res Ther; 2014 Feb; 5(1):22. PubMed ID: 24507665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury.
    Kim SH; Moon HH; Kim HA; Hwang KC; Lee M; Choi D
    Mol Ther; 2011 Apr; 19(4):741-50. PubMed ID: 21245851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
    Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
    J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-cadherin determines individual variations in the therapeutic efficacy of human umbilical cord blood-derived mesenchymal stem cells in a rat model of myocardial infarction.
    Lee EJ; Choi EK; Kang SK; Kim GH; Park JY; Kang HJ; Lee SW; Kim KH; Kwon JS; Lee KH; Ahn Y; Lee HJ; Cho HJ; Choi SJ; Oh WI; Park YB; Kim HS
    Mol Ther; 2012 Jan; 20(1):155-67. PubMed ID: 22068423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet-1 Mesenchymal Stem Cells-Derived Exosome-Incorporated Angiogenin-1 Hydrogel for Enhanced Acute Myocardial Infarction Therapy.
    Hu X; Ning X; Zhao Q; Zhang Z; Zhang C; Xie M; Huang W; Cai Y; Xiang Q; Ou C
    ACS Appl Mater Interfaces; 2022 Aug; 14(32):36289-36303. PubMed ID: 35920579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulated glucagon-like peptide-1-producing mesenchymal stem cells have a beneficial effect on failing pig hearts.
    Wright EJ; Farrell KA; Malik N; Kassem M; Lewis AL; Wallrapp C; Holt CM
    Stem Cells Transl Med; 2012 Oct; 1(10):759-69. PubMed ID: 23197668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mineralocorticoid receptor deficiency improves the therapeutic effects of mesenchymal stem cells for myocardial infarction via enhanced cell survival.
    Xie X; Shen Y; Chen J; Huang Z; Ge J
    J Cell Mol Med; 2019 Feb; 23(2):1246-1256. PubMed ID: 30549184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.